Cytokine production in motor neurons by poliovirus replicon vector gene delivery

Nature Biotechnology

Volumn 18, Issue 9, 2000, Pages 964-969

  Bledsoe, Andrea W ^a   Jackson, Cheryl A ^b   Mcpherson, Sylvia ^c   Morrow, Casey D ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Central nervous system; Gene delivery; Neoron; Replicon; Tumor necrosis factor

Indexed keywords

GREEN FLUORESCENT PROTEIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RECEPTOR; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATAXIA; CYTOKINE PRODUCTION; DEMYELINATION; GENE TARGETING; MACROGLIA; MOTONEURON; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MICROGLIA; MODELS, GENETIC; MOTOR NEURONS; MYELIN BASIC PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; POLIOVIRUS; PROMOTER REGIONS (GENETICS); RECEPTORS, VIRUS; SPINAL CORD; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ALPHAVIRUS; ANIMALIA; ATAXIA; MURINAE; MUS MUSCULUS; POLIOVIRUS;

EID: 0034425436     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/79455     Document Type: Article

References (37)

1. Histopathologic basis of clinical findings in poliomyelitis
2. Expression of human immunodeficiency virus type 1 HIV-1 gag, pol and env proteins from chimeric HIV-1-poliovirus minireplicons
3. Encapsidation of genetically engineered poliovirus mini-replicons which express HIV- 1 gag and pol proteins upon infection
4. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene using a complementation system which provides the P1 capsid protein in trans
5. Release of virus-like particles from cells infected with poliovirus replicons which express HIV-1 gag
6. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans
7. Demonstration of the specificity of poliovirus encapsidation using novel replicons which encode enzymatically active firefly luciferase
8. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons
9. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin
10. Cytokines: Influence on Glial Cell Gene Expression and Function
11. Cytokines and the Central Nervous System
12. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-α
13. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin- 2
14. A rapid assay for cytotoxicity of unstimulated human monocytes
15. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis
16. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice
17. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice
18. Transgenic mice susceptible to poliovirus
19. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
20. Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice
21. TNF-α transgenic and knockout models of CNS inflammation and degeneration
22. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4)
23. Viral and rickettsial infections of man
24. Poliovirus induces apoptosis in the mouse central nervous system
25. +2 accumulation
26. Tumor Necrosis Factor. The Good, the Bad and the Umbra
27. Perspectives series: Cytokines and the brain. Neural-immune interactions in health and disease
28. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microgllal reactivity, and demyelination in transgenic mice producing tumor necrosis factor a in the central nervous system
29. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
30. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th- 1 lymphokine subtype
31. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
32. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells
33. Treatment of genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat
34. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures
35. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice